Canada markets closed

Immuneering Corporation (IMRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.6400+0.0800 (+5.13%)
At close: 04:00PM EDT
1.7300 +0.09 (+5.49%)
After hours: 07:24PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0.455
0
316.952
2,080
2,312
Cost of Revenue
0
0
158.122
1,153
1,280
Gross Profit
0.455
0
158.83
926.888
1,031
Operating Expenses
Research Development
39,586
41,624
36,267
26,541
15,004
Selling General and Administrative
16,482
16,760
15,607
8,272
3,110
Total Operating Expenses
56,097
58,413
51,904
34,813
18,114
Operating Income or Loss
-56,096
-58,413
-51,745
-33,886
-17,083
Interest Expense
-
-
-
-
0
Total Other Income/Expenses Net
1,093
1,334
216.844
-127.063
-
Income Before Tax
-51,634
-53,472
-50,514
-33,843
-17,040
Income Tax Expense
-
-
0
-307.485
-
Income from Continuing Operations
-51,634
-53,472
-50,514
-33,536
-17,040
Net Income
-51,634
-53,472
-50,514
-33,536
-17,040
Net Income available to common shareholders
-51,634
-53,472
-50,514
-33,536
-17,040
Basic EPS
-1.86
-
-1.91
-2.46
-1.26
Diluted EPS
-1.86
-
-1.91
-2.46
-1.26
Basic Average Shares
27,699
-
26,387
13,613
13,511
Diluted Average Shares
27,699
-
26,387
13,613
13,511